Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: results of the European compassionate-use programme.
Heidenreich A, Bracarda S, Mason M, Ozen H, Sengelov L, Van Oort I, Papandreou C, Fossa S, Hitier S, Climent MA; European investigators. Heidenreich A, et al. Among authors: bracarda s. Eur J Cancer. 2014 Apr;50(6):1090-9. doi: 10.1016/j.ejca.2014.01.006. Epub 2014 Jan 31. Eur J Cancer. 2014. PMID: 24485664 Free article.
High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancer.
Ardizzoni A, Venturini M, Crinò L, Sertoli MR, Bruzzi P, Pennucci MC, Mariani GL, Garrone O, Bracarda S, Rosso R, et al. Ardizzoni A, et al. Among authors: bracarda s. Eur J Cancer. 1993;29A(5):687-92. doi: 10.1016/s0959-8049(05)80347-8. Eur J Cancer. 1993. PMID: 8385970
Ondansetron.
Roila F, Tonato M, Basurto C, Bracarda S, Sassi M, Lupattelli M, Picciafuoco M, Ballatori E, Del Favero A. Roila F, et al. Among authors: bracarda s. Eur J Cancer. 1993;29A Suppl 1:S16-21. doi: 10.1016/s0959-8049(05)80255-2. Eur J Cancer. 1993. PMID: 8427720 Review.
The medical management of prostate cancer: a multidisciplinary team approach.
Sternberg CN, Krainer M, Oh WK, Bracarda S, Bellmunt J, Ozen H, Zlotta A, Beer TM, Oudard S, Rauchenwald M, Skoneczna I, Borner MM, Fitzpatrick JM. Sternberg CN, et al. Among authors: bracarda s. BJU Int. 2007 Jan;99(1):22-7. doi: 10.1111/j.1464-410X.2006.06477.x. Epub 2006 Sep 6. BJU Int. 2007. PMID: 16956362 Review. No abstract available.
An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy.
Grünwald V, Karakiewicz PI, Bavbek SE, Miller K, Machiels JP, Lee SH, Larkin J, Bono P, Rha SY, Castellano D, Blank CU, Knox JJ, Hawkins R, Anak O, Rosamilia M, Booth J, Pirotta N, Bodrogi I; REACT Study Group. Grünwald V, et al. Eur J Cancer. 2012 Feb;48(3):324-32. doi: 10.1016/j.ejca.2011.06.054. Epub 2011 Jul 29. Eur J Cancer. 2012. PMID: 21803569 Clinical Trial.
Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial.
Porta C, Calvo E, Climent MA, Vaishampayan U, Osanto S, Ravaud A, Bracarda S, Hutson TE, Escudier B, Grünwald V, Kim D, Panneerselvam A, Anak O, Motzer RJ. Porta C, et al. Among authors: bracarda s. Eur Urol. 2012 Apr;61(4):826-33. doi: 10.1016/j.eururo.2011.12.057. Epub 2012 Jan 5. Eur Urol. 2012. PMID: 22297244 Free PMC article. Clinical Trial.
234 results